Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Theranostics|May 13, 2022
SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cellsYang Xuan, Huogang Wang, Mingo Mh Yung, et al.Pharmacological Research|August 20, 2020
MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosisDavid W Chan, Mingo Mh Yung, Yau-Sang Chan, et al.Oncoimmunology|October 25, 2019
Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8+ T cell function and survival through elevation of PD-L1Jing-Jing Wang, Michelle K Siu, Yu-Xin Jiang, et al.Theranostics|June 5, 2026
Erratum: SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells: ErratumYang Xuan, Huogang Wang, Mingo Mh Yung, et al.Frontiers in Oncology|February 7, 2013
FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1cAndy K Y Lam, Adaline W L Ngan, Man-Hong Leung, et al.Cancers|October 13, 2021
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB AxisXueyu Wang, Mingo M H Yung, Rakesh Sharma, et al.Journal of Translational Medicine|October 14, 2017
Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistryLe Ying, Feng Yan, Qiaohong Meng, et al.Frontiers in Oncology|February 14, 2022
PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-κB Signaling Pathway in Ovarian CancerYu-Xin Jiang, Michelle K Y Siu, Jing-Jing Wang, et al.Oncotarget|April 14, 2017
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancerFeng Yan, Le Ying, Xiaofang Li, et al.Clinical and Translational Medicine|December 19, 2021
Discovery and characterization of potent And-1 inhibitors for cancer treatmentJing Li, Yi Zhang, Jing Sun, et al.Pageof 6